BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31439889)

  • 1. Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages.
    Liang P; Henning SM; Guan J; Grogan T; Elashoff D; Cohen P; Aronson WJ
    Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):127-135. PubMed ID: 31439889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression.
    Liang P; Henning SM; Schokrpur S; Wu L; Doan N; Said J; Grogan T; Elashoff D; Cohen P; Aronson WJ
    Prostate; 2016 Oct; 76(14):1293-302. PubMed ID: 27338236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation-dependence on GPR120.
    Liang P; Henning SM; Grogan T; Elashoff D; Ye H; Cohen P; Aronson WJ
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):539-546. PubMed ID: 35075215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer.
    Liang P; Henning SM; Guan J; Grogan T; Elashoff D; Olefsky JM; Cohen P; Aronson WJ
    J Natl Cancer Inst; 2019 Jan; 111(1):52-59. PubMed ID: 30202902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of omega-3 fatty acid diet on prostate cancer progression and cholesterol efflux in tumor-associated macrophages-dependence on GPR120.
    Liang P; Henning SM; Grogan T; Elashoff D; Said J; Cohen P; Aronson WJ
    Prostate Cancer Prostatic Dis; 2023 Oct; ():. PubMed ID: 37872251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low carbohydrate, high protein diet suppresses intratumoral androgen synthesis and slows castration-resistant prostate tumor growth in mice.
    Fokidis HB; Yieng Chin M; Ho VW; Adomat HH; Soma KK; Fazli L; Nip KM; Cox M; Krystal G; Zoubeidi A; Tomlinson Guns ES
    J Steroid Biochem Mol Biol; 2015 Jun; 150():35-45. PubMed ID: 25797030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth.
    Arora H; Panara K; Kuchakulla M; Kulandavelu S; Burnstein KL; Schally AV; Hare JM; Ramasamy R
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11298-11303. PubMed ID: 30322928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acids decrease prostate cancer progression associated with an anti-tumor immune response in eugonadal and castrated mice.
    Gevariya N; Besançon M; Robitaille K; Picard V; Diabaté L; Alesawi A; Julien P; Fradet Y; Bergeron A; Fradet V
    Prostate; 2019 Jan; 79(1):9-20. PubMed ID: 30073695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
    Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2.
    Kobayashi N; Barnard RJ; Henning SM; Elashoff D; Reddy ST; Cohen P; Leung P; Hong-Gonzalez J; Freedland SJ; Said J; Gui D; Seeram NP; Popoviciu LM; Bagga D; Heber D; Glaspy JA; Aronson WJ
    Clin Cancer Res; 2006 Aug; 12(15):4662-70. PubMed ID: 16899616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer.
    Wang S; Wu J; Suburu J; Gu Z; Cai J; Axanova LS; Cramer SD; Thomas MJ; Perry DL; Edwards IJ; Mucci LA; Sinnott JA; Loda MF; Sui G; Berquin IM; Chen YQ
    Carcinogenesis; 2012 Feb; 33(2):404-12. PubMed ID: 22159221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6-mediated Axl and RON signaling.
    Brown NE; Jones A; Hunt BG; Waltz SE
    Prostate; 2022 Nov; 82(15):1422-1437. PubMed ID: 35860905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer.
    Han W; Gao S; Barrett D; Ahmed M; Han D; Macoska JA; He HH; Cai C
    Oncogene; 2018 Feb; 37(6):710-721. PubMed ID: 29059155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer.
    Chen X; Li Q; Liu X; Liu C; Liu R; Rycaj K; Zhang D; Liu B; Jeter C; Calhoun-Davis T; Lin K; Lu Y; Chao HP; Shen J; Tang DG
    Clin Cancer Res; 2016 Sep; 22(17):4505-16. PubMed ID: 27060154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
    Mitani T; Harada N; Tanimori S; Nakano Y; Inui H; Yamaji R
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):276-82. PubMed ID: 25297617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts.
    Adisetiyo H; Liang M; Liao CP; Jeong JH; Cohen MB; Roy-Burman P; Frenkel B
    J Cell Physiol; 2014 Sep; 229(9):1170-6. PubMed ID: 24752784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization.
    Liu Y; Zhou Q; Ye F; Yang C; Jiang H
    Neoplasia; 2023 Sep; 43():100928. PubMed ID: 37579688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment.
    Zhang Q; Liu S; Zhang Q; Xiong Z; Wang AR; Myers L; Melamed J; Tang WW; You Z
    Prostate; 2014 Jun; 74(8):869-79. PubMed ID: 24691769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
    Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
    Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data.
    Huang J; Liu D; Li J; Xu J; Dong S; Zhang H
    Ann Med; 2023; 55(2):2260387. PubMed ID: 37729607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.